Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
Beneficial Effect of Polymyxin B-immobilized Fiber Column (PMX) Hemoperfusion Treatment on Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Yoshitsugu SeoShinji AbeMisuzu KuraharaDaisuke OkadaYoshinobu SaitoJiro UsukiArata AzumaKiyoshi KoizumiShoji Kudoh
Author information

2006 Volume 45 Issue 18 Pages 1033-1038


Objective: This study was aimed to investigate the effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on the acute exacerbation of idiopathic pulmonary fibrosis (IPF).
Patients and Methods: Six patients with a clinical diagnosis of idiopathic pulmonary fibrosis (IPF) who developed acute exacerbation were included in this study. Although five of six patients were treated with high-dose corticosteroid therapy, mechanical ventilation was necessary for all six patients due to severe respiratory failure. Blood endotoxin levels were undetectable in all patients. PMX treatment was performed on these six patients.
Results: In four of six patients, alveolar-arterial difference of oxygen (AaDO2), serum KL-6 and lactate dehydrogenase (LDH) were improved after PMX treatment. These four patients were successfully weaned from mechanical ventilation and survived more than 30 days after the initial PMX treatment.
Conclusion: These data suggest a potential beneficial effect of PMX treatment on acute exacerbation of IPF.

Content from these authors
© 2006 by The Japanese Society of Internal Medicine
Previous article Next article